89 related articles for article (PubMed ID: 7648530)
1. In vitro assessments of the genetic stability of a live recombinant human adenovirus vaccine against rabies.
Lutze-Wallace C; Sapp T; Sidhu M; Wandeler A
Can J Vet Res; 1995 Apr; 59(2):157-60. PubMed ID: 7648530
[TBL] [Abstract][Full Text] [Related]
2. Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model.
Lutze-Wallace C; Sapp T; Nadin-Davis SA; Wandeler A
Can J Vet Res; 1992 Oct; 56(4):360-4. PubMed ID: 1477804
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human adenovirus 5: rabies glycoprotein recombinant vaccine reisolated from orally vaccinated skunks.
Lutze-Wallace C; Wandeler A; Prevec L; Sidhu M; Sapp T; Armstrong J
Biologicals; 1995 Dec; 23(4):271-7. PubMed ID: 8825855
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB).
Knowles MK; Roberts D; Craig S; Sheen M; Nadin-Davis SA; Wandeler AI
Vaccine; 2009 May; 27(20):2662-8. PubMed ID: 19428876
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
6. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
Zhang X; Zhang Y; Li W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
[TBL] [Abstract][Full Text] [Related]
7. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)].
Zhao ZP; Xia XZ; Hu RL; Xie ZJ; Yan F; Huang G; Yang ST
Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245
[TBL] [Abstract][Full Text] [Related]
8. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
9. Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.
Beckert A; Geue L; Vos A; Neubert A; Freuling C; Müller T
Microbiol Immunol; 2009 Jan; 53(1):16-21. PubMed ID: 19161553
[TBL] [Abstract][Full Text] [Related]
10. Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Mousli M; Turki I; Kharmachi H; Saadi M; Dellagi K
J Virol Methods; 2007 Dec; 146(1-2):246-56. PubMed ID: 17845821
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of double or triple copies of the rabies virus glycoprotein gene using a 'self-cleaving' 2A peptide-based replication-defective human adenovirus serotype 5 vector.
Tan Y; Liang H; Chen A; Guo X
Biologicals; 2010 Sep; 38(5):586-93. PubMed ID: 20682459
[TBL] [Abstract][Full Text] [Related]
12. Expression of rabies virus glycoprotein gene into eukaryotic system and determination of potential T-cell epitopes.
Tomar NR; Chandra R; Kumar R; Tiwari AK; Kumar A
Indian J Exp Biol; 2011 Aug; 49(8):594-9. PubMed ID: 21870427
[TBL] [Abstract][Full Text] [Related]
13. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
14. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
[TBL] [Abstract][Full Text] [Related]
15. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
Shen CF; Lanthier S; Jacob D; Montes J; Beath A; Beresford A; Kamen A
Vaccine; 2012 Jan; 30(2):300-6. PubMed ID: 22079076
[TBL] [Abstract][Full Text] [Related]
16. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
17. Genotyping of varicella-zoster virus strains after serial passages in cell culture.
Sauerbrei A; Philipps A; Zell R; Wutzler P
J Virol Methods; 2007 Oct; 145(1):80-3. PubMed ID: 17555827
[TBL] [Abstract][Full Text] [Related]
18. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species.
Knowles MK; Nadin-Davis SA; Sheen M; Rosatte R; Mueller R; Beresford A
Vaccine; 2009 Nov; 27(47):6619-26. PubMed ID: 19698811
[TBL] [Abstract][Full Text] [Related]
19. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
[TBL] [Abstract][Full Text] [Related]
20. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].
Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
